Neuropilin-1 (NRP1), implicated in various pro-tumorigenic processes, is a promising therapeutic target for cancer treatmentSecarna designed LNA-modified NRP1 specific antisense…
WOBURN, MA / ACCESSWIRE / November 3, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of…
BOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…
LUND, SWEDEN / ACCESSWIRE / November 3, 2023 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Tumorad® in clinicJULY - SEPTEMBER IN BRIEFNet sales…
Potential to address cancer treatment related Cytokine Release SyndromeLONDON, UK / ACCESSWIRE / November 3, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF),…
Think Research's solutions and services are part of Nova Scotia's comprehensive YourHealthNS strategy to improve access to essential health services…
Five rusfertide abstracts accepted for oral and poster presentations at the 65th ASH Annual Meeting and Exposition (ASH2023)Positive topline results…
CONSHOHOCKEN, PA / ACCESSWIRE / November 2, 2023 / In what promises to be a pivotal moment for the pharmaceutical…
Scientists at Lonza Biologics and Pressure BioSciences Presented PBIO's Patented BaroFold Platform for Breakthrough Efficiency and Economics Versus Current Manufacturing…
Two oral presentations and three poster presentations elucidate new data relevant to rusfertide, a hepcidin mimetic with potential therapeutic value…